PROSPECTUS SUPPLEMENT No. 3 Dated May 2, 2022 | Filed Pursuant to Rule 424(b)(3) |
(To Prospectus dated December 27, 2021) | Registration 333-261734 |
Recruiter.com Group, Inc.
1,707,892 shares of Common Stock
2,961,688 shares of Common Stock underlying Warrants to Purchase Common Stock
EXPLANATORY NOTE
This Prospectus Supplement No. 3 (this “Prospectus Supplement No. 3) relates to the resale by the selling security holders (the “Selling Security Holders”) identified in the prospectus dated December 27, 2021 (the “Base Prospectus”) of up to an aggregate of 4,669,580 shares of common stock, par value $0.0001 per share (the “Common Stock”) of Recruiter.com Group, Inc. (the “Company”), consisting of up to: (a) 1,707,892 shares of Common Stock, and (b) 2,961,688 shares of Common Stock issuable upon exercise of warrants (“Warrants”) that may be sold from time to time by the Selling Security Holders identified in the Base Prospectus pursuant to the registration statement that the Base Prospectus forms a part of. The Company will not receive proceeds from the sale of shares of Common Stock.
This Prospectus Supplement No. 3 should be read together with the Base Prospectus and this Prospectus Supplement No. 3 is qualified by reference to the Base Prospectus (collectively, the “Prospectus”), except to the extent that the information in this Prospectus Supplement No. 3 updates and supersedes the information contain in the Base Prospectus. This Prospectus Supplement No. 3 is not complete without and may not be delivered or utilized except in conjunction with, the Base Prospectus, including any amendments thereto.
This Prospectus Supplement No. 3 includes the attached Current Report on Form 8-K (the “Form 8-K”) of the Company for the fiscal year ended December 31, 2021, filed by the Company with the Securities and Exchange Commission on May 2, 2022.
The Company’s Common Stock and Warrants are traded on the Nasdaq Capital Market under the symbols “RCRT” and “RCRTW.”
You should rely only on the information contained in the Prospectus or any prospectus supplement or amendment hereto. The Company has not authorized anyone to provide you with different information.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this Prospectus Supplement No. 3. Any representation to the contrary is a criminal offense.
The date of this prospectus supplement is May 2, 2022.